FR
Solutions
Consulting
Products
Lab'O
Contact us
FR
EN
Menu
Tag: SPUR™
Press / Media
New study results show SPUR™ tool predicts hospital admission and early readmission
Scientific communications
SPUR as a predictor of admission and early readmission in patients living with Type 2 Diabetes
Scientific communications
Usage of the SPUR™ Adherence Profiling Tool in depression and anxiety: Initial Findings
Press / Media
Observia partners with Mapi Research Trust for the distribution of its behavioral diagnostic tool SPUR
Scientific communications
SPUR™ Phase 2 UK Study: final results
Press / Media
SPUR™ Tool Research Plan Completion
Success Stories
The first Therapeutic Patient Education platform for cardiac rehabilitation
15
jun
Events
Observia at Vivatech
Scientific communications
Understanding patients' health decisions: 13 behavioral drivers - Brochure
Articles
Understanding adherence: The 13 drivers of patients' health behavior
Scientific communications
SPUR™ Phase 2 US study: final results
Scientific communications
SPUR™ Phase 2 UK study: interim results
News
New milestone achieved presented during the EASD annual congress!
Scientific communications
Behavioral theories behind the SPUR™ model
Articles
Diagnosing patient behavior for better chronic disease management
Accès plateformes
English
Français
English
Improve patients' lives
Solutions
Understand
Personalize
Engage
Improve
Consulting
Insight generation
Implementation support
Go-to-market strategies
Products
Lab'O
The Lab Bench
The Garage
Observia
Discover us
Purpose
Story
Join us
Get in touch
Contact us
Newsletter
Follow us
insights
Press / Media
New study results show SPUR™ tool predicts hospital admission and early readmission
events
11
oct
Events
Observia at Reuters Pharma
Oct 11
st
2022 at 08h00
